Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB

New classes of antitubercular drugs, diarylquinolines and nitroimidazoles, have been associated with improved outcomes in the treatment of drug-resistant tuberculosis, but that success is threatened by emerging drug resistance. We report a case of bedaquiline and delamanid resistance in a 55-year-o...

Full description

Bibliographic Details
Main Authors: James Millard, Stephanie Rimmer, Camus Nimmo, Max O’Donnell
Format: Article
Language:English
Published: Centers for Disease Control and Prevention 2023-05-01
Series:Emerging Infectious Diseases
Subjects:
Online Access:https://wwwnc.cdc.gov/eid/article/29/5/22-1716_article
_version_ 1797843456047972352
author James Millard
Stephanie Rimmer
Camus Nimmo
Max O’Donnell
author_facet James Millard
Stephanie Rimmer
Camus Nimmo
Max O’Donnell
author_sort James Millard
collection DOAJ
description New classes of antitubercular drugs, diarylquinolines and nitroimidazoles, have been associated with improved outcomes in the treatment of drug-resistant tuberculosis, but that success is threatened by emerging drug resistance. We report a case of bedaquiline and delamanid resistance in a 55-year-old woman in South Africa with extensively drug-resistant tuberculosis and known HIV.
first_indexed 2024-04-09T17:05:33Z
format Article
id doaj.art-99de67ef3f8c4beaa458c56f115b9422
institution Directory Open Access Journal
issn 1080-6040
1080-6059
language English
last_indexed 2024-04-09T17:05:33Z
publishDate 2023-05-01
publisher Centers for Disease Control and Prevention
record_format Article
series Emerging Infectious Diseases
spelling doaj.art-99de67ef3f8c4beaa458c56f115b94222023-04-20T14:28:15ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592023-05-012951081108410.3201/eid2905.221716Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TBJames MillardStephanie RimmerCamus NimmoMax O’Donnell New classes of antitubercular drugs, diarylquinolines and nitroimidazoles, have been associated with improved outcomes in the treatment of drug-resistant tuberculosis, but that success is threatened by emerging drug resistance. We report a case of bedaquiline and delamanid resistance in a 55-year-old woman in South Africa with extensively drug-resistant tuberculosis and known HIV. https://wwwnc.cdc.gov/eid/article/29/5/22-1716_articletuberculosis and other mycobacteriabacteriaantimicrobial resistancebedaquilinedelamanidXDR TB
spellingShingle James Millard
Stephanie Rimmer
Camus Nimmo
Max O’Donnell
Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
Emerging Infectious Diseases
tuberculosis and other mycobacteria
bacteria
antimicrobial resistance
bedaquiline
delamanid
XDR TB
title Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
title_full Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
title_fullStr Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
title_full_unstemmed Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
title_short Therapeutic Failure and Acquired Bedaquiline and Delamanid Resistance in Treatment of Drug-Resistant TB
title_sort therapeutic failure and acquired bedaquiline and delamanid resistance in treatment of drug resistant tb
topic tuberculosis and other mycobacteria
bacteria
antimicrobial resistance
bedaquiline
delamanid
XDR TB
url https://wwwnc.cdc.gov/eid/article/29/5/22-1716_article
work_keys_str_mv AT jamesmillard therapeuticfailureandacquiredbedaquilineanddelamanidresistanceintreatmentofdrugresistanttb
AT stephanierimmer therapeuticfailureandacquiredbedaquilineanddelamanidresistanceintreatmentofdrugresistanttb
AT camusnimmo therapeuticfailureandacquiredbedaquilineanddelamanidresistanceintreatmentofdrugresistanttb
AT maxodonnell therapeuticfailureandacquiredbedaquilineanddelamanidresistanceintreatmentofdrugresistanttb